http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112933090-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate | 2021-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112933090-B |
| titleOfInvention | Use of deubiquitinase inhibitor in preparing medicine for anti-rabies virus |
| abstract | The invention provides the use of a deubiquitinase inhibitor in preparing a drug for anti-rabies virus, and relates to the technical field of biomedicine. The present invention shows for the first time that PR-619 has anti-rabies virus activity through experiments, and confirms that PR-619 has preventive and therapeutic effects on rabies virus infection. |
| priorityDate | 2021-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 186.